A systematic review of patient preference elicitation methods in the treatment of colorectal cancer

Colorectal Disease

Volumn 17, Issue 1, 2015, Pages 17-25

  Currie, A ^a   Askari, A ^a   Nachiappan, S ^a   Sevdalis, N ^b   Faiz, O ^a,b   Kennedy, R ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Colorectal cancer; Decision making; Oncology; Patient preference; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; HUMAN; INTESTINE FUNCTION; LIFE EXPECTANCY; META ANALYSIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT DECISION MAKING; PATIENT PREFERENCE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; ADJUVANT THERAPY; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; DECISION MAKING; INTERPERSONAL COMMUNICATION; PSYCHOLOGY; RISK;

COLORECTAL NEOPLASMS; COLORECTAL SURGERY; COMMUNICATION; DECISION MAKING; HUMANS; NEOADJUVANT THERAPY; PATIENT PREFERENCE; QUALITY OF LIFE; RISK;

EID: 84923045359     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12754     Document Type: Article

References (39)

1. Holzer B, Gyasi A, Schiessel R et al. Patients' expectations of colorectal surgery for cancer. Colorectal Dis 2006; 8: 186-91.
2. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2012; (12): CD004323.
3. Pieterse AH, Baas-Thijssen MC, Marijnen CA et al. Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer 2008; 99: 875-82.
4. Masya LM, Young JM, Solomon MJ et al. Preferences for outcomes of treatment for rectal cancer: patient and clinician utilities and their application in an interactive computer-based decision aid. Dis Colon Rectum 2009; 52: 1994-2002.
5. Lamb BW, Taylor C, Lamb JN et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann Surg Oncol 2013; 20: 1408-16.
6. Lamb BW, Brown KF, Nagpal K et al. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol 2011; 18: 2116-25.
7. McNair AG, Brookes ST, Kinnersley P et al. What surgeons should tell patients with oesophago-gastric cancer: a cross sectional study of information needs. Eur J Surg Oncol 2013; 39: 1278-86.
8. Blinman P, King M, Norman R et al. Preferences for cancer treatments: an overview of methods and applications in oncology. Ann Oncol 2012; 23: 1104-10.
9. Nakajima T, Saito Y, Tanaka S et al. Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan. Surg Endosc 2013; 27: 3262-70.
10. Transanal Endoscopic Microsurgery (TEM) and Radiotherapy in Early Rectal Cancer (TREC) Trial. Birmingham Clinical Trials Unit. http://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/coloproctology/trec/index.aspx. (accessed 31 March 2014).
11. Habr-Gama A, Sabbaga J, Gama-Rodrigues J et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 2013; 56: 1109-17.
12. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
13. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org (accessed 31 March 2014).
14. NHS Centre for Reviews and Dissemination. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Healthcare. York: Centre for Reviews and Dissemination, 2009.
15. Blinman P, Duric V, Nowak AK et al. Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile? Eur J Cancer 2010; 46: 1800-7.
16. Bossema E, Stiggelbout A, Baas-Thijssen M et al. Patients' preferences for low rectal cancer surgery. Eur J Surg Oncol 2008; 34: 42-8.
17. Couture J, Chan R, Bouharaoui F. Patient's preferences for adjuvant postoperative chemoradiation therapy in rectal cancer. Dis Colon Rectum 2005; 48: 2055-60.
18. Harrison JD, Solomon MJ, Young JM et al. Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. Arch Surg 2008; 143: 389-94.
19. Hofmann S, Vetter J, Wachter C et al. Visual AIDS for multimodal treatment options to support decision making of patients with colorectal cancer. BMC Med Inform Decis Mak 2012; 12: 118.
20. Pieterse AH, Stiggelbout AM, Baas-Thijssen MC et al. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences. Br J Cancer 2007; 97: 717-24.
21. Solomon MJ, Pager CK, Keshava A et al. What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer. Dis Colon Rectum 2003; 46: 1351-7.
22. Zolciak A, Bujko K, Kepka L et al. Abdominoperineal resection or anterior resection for rectal cancer: patient preferences before and after treatment. Colorectal Dis 2006; 8: 575-80.
23. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
24. Marijnen CA, van de Velde CJ, Putter H et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005; 23: 1847-58.
25. Peeters KC, Marijnen CA, Nagtegaal ID et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
26. Moertel CG, Fleming TR, Macdonald JS et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
27. Andre T, Boni C, Mounedji-Boudiaf L et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-51.
28. Soerjomataram I, Lortet-Tieulent J, Parkin DM et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 2012; 380: 1840-50.
29. Burns EM, Bottle A, Aylin P et al. Variation in reoperation after colorectal surgery in England as an indicator of surgical performance: retrospective analysis of Hospital Episode Statistics. BMJ 2011; 343: d4836.
30. Blinman P, Alam M, Duric V et al. Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review. Lung Cancer 2010; 69: 141-7.
31. Jansen SJ, Otten W, Stiggelbout AM. Review of determinants of patients' preferences for adjuvant therapy in cancer. J Clin Oncol 2004; 22: 3181-90.
32. McCulloch P, Nagendran M, Campbell WB et al. Strategies to reduce variation in the use of surgery. Lancet 2013; 382: 1130-9.
33. Slevin ML, Stubbs L, Plant HJ et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990; 300: 1458-60.
34. Lloyd A, van Hanswijck de Jonge P, Doyle S et al. Health state utility scores for cancer-related anemia through societal and patient valuations. Value Health 2008; 11: 1178-85.
35. Angelos P. Ethical issues of participant recruitment in surgical clinical trials. Ann Surg Oncol 2013; 20: 3184-7.
36. McNair AG, Choh CT, Metcalfe C et al. Maximising recruitment into randomised controlled trials: the role of multidisciplinary cancer teams. Eur J Cancer 2008; 44: 2623-6.
37. Avery KN, Barham CP, Berrisford R et al. Understanding surgical interventions in RCTs: the need for better methodology. Lancet 2013; 381: 27-8.
38. Anandadas CN, Clarke NW, Davidson SE et al. Early prostate cancer - which treatment do men prefer and why? BJU Int 2011; 107: 1762-8.
39. Post PN, Kil PJ, Hendrikx AJ et al. Comorbidity in patients with prostate cancer and its relevance to treatment choice. BJU Int 1999; 84: 652-6.